Global Flow Cytometry Market Analysis Report 2022-2027 – Rising Autoimmune Disease Prevalence and Increasing Advances in Flow Cytometry Techniques Drive Market Growth – Yahoo Finance | Team Cansler

DUBLIN, November 18, 2022 /PRNewswire/ — The “Global Flow Cytometry Market by Technology (Cell-Based, Bead-Based), Product and Service (Analyzer, Sorter, Consumables, Software), Application ((Research – Immunology, Stem Cells), (Clinical – Hematology)) , Consumers (Biotech, Hospitals) – Forecast to 2027″ was added ResearchAndMarkets.com Offer.

Research_and_Markets_Logo

Research_and_Markets_Logo

The global flow cytometry market is expected to range $6.9 billion until 2027 $4.7 billion in 2022 at a CAGR of 8.1%

The rising prevalence of HIV/AIDS, cancer and autoimmune diseases around the world is increasing the adoption of flow cytometry for diagnosis, hence predicting market growth. Moreover, the introduction of technologically innovative products is expected to further drive the market growth during the forecast period 2022-2027.

The instrument segment had a significant share of the global flow cytometry market in 2021.

Based on Products and Services, the market is segmented into Reagents & Consumables, Instruments, Services, Software and Accessories. The reagents and consumables segment had a dominant market share in 2021 and is expected to continue to dominate during the forecast period.

The introduction of new reagents and consumables in the market, which make the research grow faster, is expected to drive the growth of the segment. in the November 2021Bio-Rad Laboratories, Inc. (USA), launched StarBright UltraViolet 400 Dye, fluorescent nanoparticles designed for use with a UV laser in flow cytometry applications.

The research applications segment dominated the market in 2021.

Based on end-user, the flow cytometry market is segmented into research applications, clinical applications, and industrial applications.

The strong focus of key market players on the clinical applications of flow cytometry is likely to project segment growth. For example in October 2021BD (Becton, Dickinson and Company) (USA), in collaboration with the Christian Medical College Vellore (India) has established its second Center of Excellence (CoE) in flow cytometry for clinical research India.

North America held a dominant stake in 2021.

Geographically, the flow cytometry market is segmented into North America, Europe, Asia Pacific, Latin Americaand the middle East and Africa. 2021, North America accounted for the largest share of the flow cytometry market. North America held a dominant share due to the presence of key market players coupled with the increasing adoption of flow cytometry in research applications in the region.

That Asia Pacific is expected to grow faster due to increasing research funding and the adoption of flow cytometry in clinical applications.

competitive landscape

The leading players in the flow cytometry market are Becton, Dickinson and Company (USA), Danaher Corporation (USA), Thermo Fisher Scientific, Inc. (USA), Agilent Technologies, Inc. (USA) and Luminex Corporation (USA).

Premium Insights

  • The increasing prevalence of autoimmune diseases and increasing advances in flow cytometry techniques are driving the market growth

  • The reagents and consumables segment accounted for the largest share in 2021

  • Cell-based flow cytometry segment is expected to dominate the market during the forecast period

  • China to register the highest growth during the forecast period

market dynamics

driver

  • Increasing incidence of HIV/AIDS and cancer

  • Flow cytometry techniques in research activities

  • Use of flow cytometry in regenerative medicine

  • Growing public-private initiatives in immunology and immuno-oncology research

  • Technological advances in flow cytometry instruments

limitations

occasions

challenges

patent analysis

Analysis of the value chain

  • ecosystem analysis

  • role in the ecosystem

Regulatory Assessment

  • Strict FDA requirements

  • Rule for analyte-specific reagents

  • Limitations in validation protocols for cell-based assays

  • Lack of test guidelines for cell-based fluorescence assays

  • IVD CE approvals

USA: reimbursement scenario

company profiles

key figures

  • BD

  • Danaher Corporation

  • Thermo Fisher Scientific, Inc.

  • Agilent Technologies, Inc.

  • Sony Biotechnology Inc. (A subsidiary of Sony Group Corporation)

  • Bio-Rad Laboratories Inc.

  • Miltenyi Biotec

  • Enzo Biochem, Inc.

  • Sysmex Corporation

  • Luminex Corporation (A Diasorin Company)

  • Biomerieux SA

  • Cytonome/St, LLC.

  • Sartorius AG

  • Cytek Biosciences

  • Union Biometrica, Inc.

other players

  • Apogee Flow Systems Ltd.

  • Strategy, Inc.

  • Nanocellect Biomedical, Inc.

  • On Chip Biotechnologies Co.Ltd.

  • Nexcelom Bioscience LLC.

  • Bennubio Inc.

  • Orflo Technologies

  • Bay Bioscience Co.Ltd.

  • Cytobuoy BV

  • Biolegend, Inc.

For more information about this report, visit https://www.researchandmarkets.com/r/876tbp

Media contact:

research and markets
Laura WoodSenior managers
press@researchandmarkets.com

For EST office hours, call +1-917-300-0470
For US/CAN, call toll free +1-800-526-8630
For GMT office hours, call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

decision

decision

View original content: https://www.prnewswire.com/news-releases/global-flow-cytometry-market-analysis-report-2022-2027—increasing-prevalence-of-autoimmune-diseases-and-rising- advances -flow-cytometry-techniques-drive-market-growth-301682642.html

SOURCE Research and Markets

Leave a Comment